The HIV protease inhibitor Indinavir reduces immature dendritic cell transendothelial migration

European Journal of Immunology

Volumn 33, Issue 9, 2003, Pages 2520-2530

  Whelan, Kathryn T ^a   Lin, Chen Lung ^c   Cella, Marina ^d   McMichael, Andrew J ^a   Austyn, Jonathan M ^b   Rowland Jones, Sarah L ^a  

^a UNIVERSITY OF OXFORD   (United Kingdom)

^b UNIVERSITY OF OXFORD   (United Kingdom)

^c UNIVERSITY OF HONG KONG   (Hong Kong)

^d WASHINGTON UNIVERSITY   (United States)

Author keywords

Adhesion molecules; Cell trafficking; Dendritic cells; HIV; Indinavir

Indexed keywords

ANTIRETROVIRUS AGENT; BETA1 INTEGRIN; CD209 ANTIGEN; CELL ADHESION MOLECULE; CHEMOKINE; FIBRONECTIN; INDINAVIR; INTERCELLULAR ADHESION MOLECULE 2; MONOCLONAL ANTIBODY; PROTEINASE; PROTEINASE INHIBITOR; UNCLASSIFIED DRUG; VERY LATE ACTIVATION ANTIGEN 5;

ARTICLE; CELL ADHESION; CELL MATURATION; CELL MIGRATION; CONTROLLED STUDY; CORRELATION ANALYSIS; DENDRITIC CELL; DRUG EXPOSURE; HUMAN; HUMAN CELL; HUMAN IMMUNODEFICIENCY VIRUS 1; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; IMMUNOREGULATION; MONOCYTE; PHENOTYPE; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN PROTEIN INTERACTION; VIRUS REPLICATION;

ANTIGENS, CD; CELL ADHESION MOLECULES; CELL MOVEMENT; DENDRITIC CELLS; ENDOTHELIUM; HIV INFECTIONS; HIV PROTEASE INHIBITORS; HIV-1; HUMANS; IMMUNOGLOBULINS; INDINAVIR; INTEGRIN ALPHA4BETA1; INTEGRIN ALPHA5BETA1; LECTINS, C-TYPE; MEMBRANE GLYCOPROTEINS; RECEPTORS, CELL SURFACE;

EID: 0141523173     PISSN: 00142980     EISSN: None     Source Type: Journal    
DOI: 10.1002/eji.200323646     Document Type: Article

References (36)

1. + T cell depletion in HIV disease. Nature 2001. 410: 974-979.
2. McMichael, A. J. and Rowland-Jones, S. L., Cellular immune responses to HIV. Nature 2001. 410: 980-987.
3. Austyn, J. M., Dendritic cells. Curr. Opin. Hematol 1998. 5: 3-15.
4. Lin, C.-L., Suri, R. M., Rhadon, R., Austyn, J. M. and Roake, J. A., Dendritic cell chemotaxis and transendothelial migration are induced by distinct chemokines and are regulated on maturation. Eur. J. Immunol. 1998. 28: 1-9.
5. Rubbert, A., Combadiere, C., Ostrowski, M., Arthos, J., Dybul, M., Machado, E., Cohn, M. A., Hoxie, J. A., Murphy, P. M., Fauci, A. S. and Weissman, D., Dendritic cells express multiple chemokine receptors used as corecptors for HIV entry. J. Immunol. 1998. 160: 3933-3941.
6. Geijtenbeek, T. B., Kwon, D. S., Torensma, R., van Vliet, S. J., van Duijnhoven, G. C., Middel, J., Cornelissen, I. L., Nottet, H. S., KewalRamani, V. N., Littman, D. R., Figdor, C. G. and van Kooyk, Y., DC-SIGN, a dendritic cell-specific HIV-1-binding protein that enhances trans-infection of T cells. Cell 2000. 100: 587-597.
7. Geijtenbeek, T. B., Torensma, R., van Vliet, S. J., van Duijnhoven, G. C., Adema, G. J., van Kooyk, Y. and Figdor, C. G., Identification of DC-SIGN, a novel dendritic cell-specific ICAM-3 receptor that supports primary immune responses. Cell 2000. 100: 575-585.
8. Geijtenbeek, T. B., Krooshoop, D. J. E. B., Bleijs, D. A., van Vliet, S. J., van Duijnhoven, G. C., Grabovsky, V., Alon, R., Figdor, C. G. and van Kooyk, Y., DC-SIGN-ICAM-2 interaction mediates dendritic cell trafficking. Nat. Immunol. 2000. 1: 353-357.
9. Perrin, L. and Telenti, A., HIV treatment failure: testing for HIV resistance in clinical practice. Science 1998. 280: 1871-1873.
10. Martin, J. A., Recent advances in the design of HIV protease inhibitors. Antiviral Res. 1992. 17: 265-278.
11. Carr, A., Samaras, K., Thoristottir, A., Kaufman, G., Chisholm, D. J. and Cooper, D. A., Natural history, diagnosis and prediction of HIV-Pr inhibitor-associated lipodystrophy, hyperlipidaemia and diabetes mellitus. Lancet 1999. 253: 2093-2099.
12. Andre, P., Groettrup, M., Klenerman, P., De Giuli, R., Booth, B. L., Cerundolo, V., Bonneville, M., Jotereau, F., Zinkernagel, R. M. and Lotteau, V., An inhibitor of HIV-1 protease modulates proteasome activity, antigen presentation, and T cell responses. Proc. Natl. Acad. Sci. USA 1998. 95: 13120-13124.
13. Chavan, S., Kodoth, S., Pahwa, R. and Pahwa, S., The HIV protease inhibitor Indinavir inhibits cell-cycle progression in vitro in lymphocytes of HIV-infected and uninfected individuals. Blood 2001. 98: 383-389.
14. Springer, T. A., Traffic signals on endothlium for lymphocyte recirculation and leukocyte emigration. Annu. Rev. Physiol 1995. 57: 827-872.
15. Hynes, R. O., Integrins: Bidirectional, allosteric signaling machines. Cell 2002. 110: 673-687.
16. Tomasselli, A. G. and Heinrikson, R. L., Targeting the HIV-protease in AIDS therapy: a current clinical perspective. Biochim. Biophys. Acta 2000. 1477: 189-214.
17. Jakob, T., Ring, J. and Udey, M. C., Multistep navigation of Langerhans/dendritic cells in and out of the skin. J. Allergy Clin. Immunol. 2001. 108: 688-696.
18. Sozzani, S., Allavena, P., D'Amico, G., Luini, W., Bianchi, G., Kataura, M., Imai, T., Yoshie, O., Bonecchi, R. and Mantovani, A., Differential regulation of chemokine receptors during dendritic cell maturation: a model for their trafficking properties. J. Immunol. 1998. 161: 1083-1086.
19. Lauritzen, E., Moller, S. and Leerhoy, J., Leukocyte migration inhibition in vitro with inhibitors of aspartic and sulphhydryl proteinases. Acta Pathol. Microbiol. Immunol. Scand. 1984. 92: 107-112.
20. Takagi, J., Erickson, H. P. and Springer, T. A., C-terminal opening mimics 'inside-out' activation of integrin alpha5beta1. Nat. Struct. Biol. 2001. 8: 412-416.
21. Nortamo, P., Li, R., Renkonen, R., Timonen, T., Prieto, J., Pataroyo, M. and Gahmberg, C., the expression of human intercellular adhesion molecule-2 is refractory to inflammatory cytokines. Eur. J. Immunol. 1991. 21: 2629-2632.
22. Bianchi, G., D'Amico, G., Varone, L., Sozzani, S., Mantovani, A. and Allavena, P., In vitro studies on the trafficking of dendritic cells through endothelial cells and extra-cellular matrix. Dev. Immunol. 2000. 7: 143-153.
23. Le Varlet, B., Staquet, M. J., Dezutter-Dambuyant, C., Delorme, P. and Schmitt, D., In vitro adhesion of human epidermal Langerhans cells to laminin and fibronectin occurs through β1 integrin receptors. J. Leukoc. Biol. 1992. 51: 415-420.
24. Stewart, M. and Hogg, N., Regulation of leukocyte integrin function: affinity vs. avidity. J. Cell. Biochem. 1996. 61: 554-561.
25. Worthylake, R. A. and Burridge, K., Leukocyte transendothelial migration: orchestrating the underlying molecular machinery. Curr. Opin. Cell Biol. 2001. 13: 569-577.
26. Lin, C. L., Sewell, A. K., Gao, G. F., Whelan, K. T., Phillips, R. E. and Austyn, J. M., Macrophage-tropic HIV induces and exploits dendritic cell chemotaxis. J. Exp. Med. 2000. 192: 587-594.
27. Gruber, A., Wheat, J. C., Kuhen, K. L., Looney, D. J. and Wong-Staal, F., Differential effects of HIV-1 protease inhibitors on dendritic cell immunophenotype and function. J. Biol. Chem. 2001. 276: 47840-47843.
28. Jenne, L., Hauser, C., Arrighi, J. F., Saurat, J. H. and Hugin, A. W., Poxvirus as a vector to transduce human dendritic cells for immunotherapy: abortive infection but reduced APC function. Gene Ther. 2000. 7: 1575-1583.
29. + T cells. J. Immunol. 2001. 166: 3865-3872.
30. Lechmann, M., Krooshoop, D. J. E. B., Dudziak, D., Kremmer, E., Kuhnt, C., Figdor, C. G., Schuler, G. and Steinkasserer, A., The extracellular domain of CD83 inhibits dendritic cell-mediated T cell stimulation and binds to a ligand on dendritic cells. J. Exp. Med. 2001. 194: 1813-1821.
31. + T cell development in the thymus. Cell 2002. 108: 755-767.
32. Alexander, J. M., Nelson, C. A., van Berkel, V., Lau, E. K., Studts, J. M., Brett, T. J., Speck, S. H., Handel, T. M., Virgin, H. W. and Femont, D. H., Structural basis of chemokine sequestration by a herpesvirus decoy receptor. Cell 2002. 111: 343-356.
33. Hock, B. D., Kato, M., McKenzie, J. L. and Hart, D. N. J., A soluble form of CD83 is released from activated dendritic cells and B lymphocytes, and is detected in normal human sera. Int. Immunol. 2001. 13: 959-967.
34. Sallusto, F. and Lanzavecchia, A., Efficient presentation of soluble antigen by cultured human dendritic cells is maintained by granulocyte/macrophage colony stimulating factor plus interleukin-4 and down-regulated by tumour necrosis factor alpha. J. Exp. Med. 1994. 179: 1109-1118.
35. Bird, I. N., Spragg, J. H., Ager, A. and Matthews, N., Studies of lymphocyte transendothelial migration: analysis of cell phenotypes with regard to CD31 (PECAM-1), CD45RA and CD45RO. Immunology 1993. 80: 553-560.
36. Geijtenbeek, T. B., van Kooyk, Y., van Vliet, S. J., Renes, M. H., Raymakers, R. A. P. and Figdor, C. G., High frequency of adhesion defects in B-lineage lymphoblastic leukemia. Blood 1999. 94: 754-764.